Fairfield operates a federated marketplace that connects sovereign owners of genomic data with researchers, keeping the data on the provider’s infrastructure until a legal contract is signed.
Funding
Funding not disclosed
Founders
Product
Problem
Most genomic datasets are held by sovereign entities—countries, institutions, and communities—that lack trusted commercial mechanisms to share their data, leading to a massive underutilization of biological information for research and development. Existing policy frameworks, such as the Nagoya Protocol, provide legal guidelines but no infrastructure to ensure data providers receive legal protection, validation, and revenue, resulting in a high rejection rate for data access requests.
Solution
Fairfield operates a federated marketplace that connects sovereign owners of genomic data with researchers seeking validated, legally compliant datasets. The platform keeps data on the provider’s infrastructure, preserving sovereignty until a contract is executed. It offers standardized contractual terms and automated revenue distribution, ensuring providers are compensated when their data contributes to commercial outcomes such as drug discovery or AI model training. For non‑commercial research, validated data can be accessed free of charge, promoting broader scientific use while maintaining legal compliance. By adding a commercial layer to existing policy, Fairfield unlocks underutilized biological data for applications in biotechnology, agriculture, and materials science.
Target Audience
Primary customers are sovereign data custodians—including national biobanks, research institutions, and agricultural consortia—seeking to monetize and share their genomic collections, as well as pharmaceutical, biotech, and AI companies that require legally vetted genomic data for product development.
Features
- Federated architecture that stores genomic data on the provider’s own servers, preventing data transfer until a legal agreement is signed
- Automated contract generation and enforcement that align with international frameworks like the Nagoya Protocol
- Revenue-sharing engine that distributes financial returns to data providers based on commercial utilization of their datasets
- Validation workflow that certifies data quality and legal compliance before it is made available to researchers
- Free access tier for validated non‑commercial research, encouraging open scientific collaboration
- API and integration tools that allow researchers to discover, request, and ingest datasets directly into their pipelines